CLSK saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 29, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 40 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLSK as a result. In 73 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
CLSK moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CLSK crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
The 50-day moving average for CLSK moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLSK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for CLSK entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CLSK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Seasonality Score of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.749) is normal, around the industry mean (3.532). P/E Ratio (-2.156) is within average values for comparable stocks, (8.846). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.708) among similar stocks. P/S Ratio (5.397) is also within normal values, averaging (16.763).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. CLSK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLSK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The RSI Oscillator for CTEV moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In 35 of the 41 cases the stock moved higher. This puts the odds of a move higher at 85%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 55 cases where CTEV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for CTEV just turned positive on October 08, 2026. Looking at past instances where CTEV's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.
Following a +4.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTEV advanced for three days, in 222 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
CTEV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTEV as a result. In 70 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
CTEV moved below its 50-day moving average on September 17, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CTEV crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTEV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CTEV entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.323) is normal, around the industry mean (3.981). P/E Ratio (-1.353) is within average values for comparable stocks, (13.628). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (0.562) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. CTEV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTEV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
CLSK | CTEV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 67 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 32 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 90 | 79 | |
P/E GROWTH RATING 1..100 | 97 | 18 | |
SEASONALITY SCORE 1..100 | 47 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CTEV's Valuation (32) in the null industry is somewhat better than the same rating for CLSK (65). This means that CTEV’s stock grew somewhat faster than CLSK’s over the last 12 months.
CTEV's Profit vs Risk Rating (100) in the null industry is in the same range as CLSK (100). This means that CTEV’s stock grew similarly to CLSK’s over the last 12 months.
CLSK's SMR Rating (98) in the null industry is in the same range as CTEV (100). This means that CLSK’s stock grew similarly to CTEV’s over the last 12 months.
CTEV's Price Growth Rating (79) in the null industry is in the same range as CLSK (90). This means that CTEV’s stock grew similarly to CLSK’s over the last 12 months.
CTEV's P/E Growth Rating (18) in the null industry is significantly better than the same rating for CLSK (97). This means that CTEV’s stock grew significantly faster than CLSK’s over the last 12 months.
| CLSK | CTEV | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| Stochastic ODDS (%) | 1 day ago 86% | 1 day ago 84% |
| Momentum ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 89% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 89% | 1 day ago 90% |
| Advances ODDS (%) | N/A | 1 day ago 79% |
| Declines ODDS (%) | 9 days ago 88% | 4 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 84% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLSK’s FA Score shows that 0 FA rating(s) are green while CTEV’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLSK’s TA Score shows that 3 TA indicator(s) are bullish while CTEV’s TA Score has 5 bullish TA indicator(s).
CLSK (@Investment Banks/Brokers) experienced а -12.83% price change this week, while CTEV (@Services to the Health Industry) price change was -3.93% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -5.38%. For the same industry, the average monthly price growth was -17.06%, and the average quarterly price growth was -13.36%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.
CLSK is expected to report earnings on Nov 24, 2026.
CTEV is expected to report earnings on Nov 09, 2026.
These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
@Services to the Health Industry (-1.51% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
A.I.dvisor indicates that over the last year, CTEV has been loosely correlated with COMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CTEV jumps, then COMP could also see price increases.
| Ticker / NAME | Correlation To CTEV | 1D Price Change % | ||
|---|---|---|---|---|
| CTEV | 100% | +2.17% | ||
| COMP - CTEV | 36% Loosely correlated | +2.57% | ||
| CLSK - CTEV | 36% Loosely correlated | -6.86% | ||
| RIOT - CTEV | 34% Loosely correlated | -8.06% | ||
| COIN - CTEV | 32% Poorly correlated | -4.51% | ||
| TGL - CTEV | 30% Poorly correlated | -8.77% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PSL | 115.72 | 2.72 | +2.41% |
| Invesco Dorsey Wright Consumer Staples Momentum ETF (PSL) | |||
| QLTI | 27.98 | 0.24 | +0.86% |
| GMO International Quality ETF | |||
| SAT | 25.06 | N/A | N/A |
| Saratoga Investment Corp | |||
| IQDF | 33.51 | -0.53 | -1.56% |
| Northern Trust International Quality Dividend ETF (IQDF) | |||
| MST | 12.63 | -1.33 | -9.55% |
| Defiance Leveraged Long Income MSTR ETF (MST) | |||